It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Liver and lymph node sinusoidal endothelial cell C-type lectin (LSECtin) plays an important regulatory role in a variety of diseases, including tumors. However, the underlying mechanism of LSECtin in gastric cancer (GC) remains largely unknown. In our research, LSECtin promoted the adhesion and invasion of GC cells, and was involved in lymphatic metastasis of GC cells. Mechanistically, LSECtin promoted the adhesion, proliferation and migration of GC cells by downregulating STAT1 expression. The circular RNA circFBXL4, which is regulated by LSECtin, sponges the microRNA miR-146a-5p to regulate STAT1 expression. The promotion of GC cell proliferation, migration and invasion mediated by LSECtin was largely inhibited by circFBXL4 overexpression or miR-146a-5p silencing. Moreover, in its role as a transcription factor, STAT1 modulated the expression of FN1 and CHD4. In conclusion, LSECtin might be involved in the lymphatic metastasis of GC by upregulating the expression of FN1 and CHD4 via the circFBXL4/miR-146a-5p/STAT1 axis, possibly indicating a newly discovered pathogenic mechanism.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Department of General Surgery, The Second Hospital of Dalian Medical University, Dalian, China (GRID:grid.452828.1) (ISNI:0000 0004 7649 7439); Dalian Medical University, Department of Clinical Biochemistry, College of Laboratory Medicine, Dalian, China (GRID:grid.411971.b) (ISNI:0000 0000 9558 1426)
2 Department of General Surgery, The Second Hospital of Dalian Medical University, Dalian, China (GRID:grid.452828.1) (ISNI:0000 0004 7649 7439)
3 Dalian Medical University, Department of Clinical Biochemistry, College of Laboratory Medicine, Dalian, China (GRID:grid.411971.b) (ISNI:0000 0000 9558 1426)
4 Dalian Medical University, Department of Functional Laboratory, College of Laboratory Medicine, Dalian, China (GRID:grid.411971.b) (ISNI:0000 0000 9558 1426)
5 Dalian Medical University, Department of Pathology and Forensics, Dalian, China (GRID:grid.411971.b) (ISNI:0000 0000 9558 1426)